Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

γδ T Cell Immunotherapy for Treatment of Gastric Cancer

NCT02585908 is registered in ClinicalTrials.gov with Beijing Doing Biomedical Co., Ltd. as lead sponsor.

NCT NCT02585908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02585908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
γδ T Cell Immunotherapy for Treatment of Gastric Cancer
Lead sponsor
Beijing Doing Biomedical Co., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
December 31, 2019
Completion date
December 31, 2022
Enrollment
120 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer